Loading…
CONMED Corporation is projected to rise to $40.14 by 2027, a +13% move from its current price of $35.48. CNMD is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $34.79 | $35.49 | $36.19 | +0.02% |
| May 30 | $34.52 | $35.49 | $36.49 | +0.03% |
| May 31 | $34.31 | $35.50 | $36.73 | +0.05% |
| Jun 1 | $34.13 | $35.50 | $36.93 | +0.07% |
| Jun 2 | $33.98 | $35.51 | $37.11 | +0.09% |
| Jun 3 | $33.85 | $35.52 | $37.27 | +0.10% |
| Jun 4 | $33.72 | $35.52 | $37.42 | +0.12% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $33.72 | $35.52 | $37.42 | +0.12% |
| Week 2 | $33.04 | $35.56 | $38.28 | +0.24% |
| Week 3 | $32.54 | $35.61 | $38.97 | +0.36% |
| Week 4 | $32.13 | $35.65 | $39.56 | +0.48% |
| Week 5 | $31.77 | $35.69 | $40.10 | +0.60% |
| Week 6 | $31.46 | $35.73 | $40.59 | +0.72% |
| Week 7 | $31.18 | $35.78 | $41.06 | +0.84% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
CONMED Corporation is a medical technology company that develops, manufactures, and sells devices and equipment for surgical procedures. Its orthopedic surgery product line includes BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, along with powered resection instruments, fluid management, visualization systems, and related single-use products that enable minimally invasive sports medicine surgeries. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors.
The company was incorporated in 1970 and is headquartered in Largo, Florida.
CONMED Corporation (CNMD) is a healthcare stock currently trading at $37.23 with a market cap of $1.12B and a rank of 2450. The current price sits near key moving averages, with the 50-day simple moving average at $36.79 and the 200-day simple moving average at $43.11. Over the last 30 days, the price has traded between $32.70 and $42.38.
The forecast shows a multi-year path of gains, with the 2026 average price equal to $37.23 and a long-run rise to an average of $179.58 by 2050, while maximums climb to $66.97 (2030), $174.47 (2040), and $297.62 (2050). The projected ROI grows to 382.4% by 2050, and sentiment is bullish in the later years.
A major floor 8.8% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.7% away) — a key level to hold.
The nearest ceiling, 11.8% above — a clean break opens room to run.
A major ceiling 29.8% above — clearing it would confirm fresh momentum.
Key CNMD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CNMD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $36.56 | Sell | $36.21 | Sell |
| MA 10 | $36.30 | Sell | $36.35 | Sell |
| MA 20 | $36.41 | Sell | $36.56 | Sell |
| MA 50 | $36.73 | Sell | $37.37 | Sell |
| MA 100 | $39.21 | Sell | $39.08 | Sell |
| MA 200 | $42.93 | Sell | $43.08 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 43.61 | Neutral |
| Stoch RSI (14) | 20.51 | Neutral |
| CCI (20) | -103.75 | Sell |
| Williams %R (14) | -91.29 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | -3.48 | Sell |
| Bollinger %B (20,2) | 0.17 | Neutral |
| Stochastic %K (14) | 8.71 | Buy |
| TRIX (15) | -0.11 | Sell |
| Awesome (5,34) | -0.60 | Sell |
| Ultimate (7,14,28) | 46.69 | Neutral |
| Momentum (10) | -0.49 | Sell |
| Aroon Osc (25) | -52.00 | Sell |
| Hull MA (9) | 36.47 | Sell |
| ADX (14) | 9.51 | Neutral |
| ATR (14) | 0.74 | Info |
RSI(14) is 50, indicating neutral momentum in the near term. The 50-day SMA is $36.79 and the 200-day SMA is $43.11. A defined support level sits at $35.23 and a resistance level at $39.73. The 30-day trading range spans $32.70 to $42.38, outlining near-term volatility and potential test points around the resistance level.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $33.49 | $35.48 | $45.92 | 0% | Neutral | |
| $32.70 | $40.14 | $51.65 | +13% | Neutral | |
| $33.79 | $42.27 | $55.86 | +19% | Neutral | |
| $34.16 | $43.41 | $58.61 | +22% | Bullish | |
| $34.49 | $44.45 | $61.11 | +25% | Bullish | |
| $36.29 | $47.36 | $66.16 | +33% | Bullish | |
| $43.57 | $57.53 | $81.54 | +62% | Bullish | |
| $46.79 | $62.46 | $89.72 | +76% | Bullish | |
| $46.57 | $62.81 | $91.31 | +77% | Bullish | |
| $49.29 | $67.14 | $98.74 | +89% | Bullish | |
| $68.45 | $97.44 | $150.35 | +175% | Bullish | |
| $99.62 | $152.67 | $252.98 | +330% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $33.49 | $35.48 | $41.51 | +0.00% |
| June 2026 | $30.22 | $35.28 | $42.00 | -0.56% |
| July 2026 | $30.68 | $36.03 | $43.32 | +2.14% |
| August 2026 | $31.41 | $37.06 | $44.89 | +2.84% |
| September 2026 | $31.01 | $36.73 | $44.76 | -0.89% |
| October 2026 | $30.49 | $36.24 | $44.42 | -1.32% |
| November 2026 | $30.91 | $36.85 | $45.39 | +1.69% |
| December 2026 | $31.03 | $37.11 | $45.92 | +0.69% |
Click any year to see its month-by-month CNMD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, CNMD is projected to trade between $33.49 and $45.92, averaging $35.48 — a potential gain of 0% from today's $35.48. A consolidation phase looks the most probable path here.
CONMED Corporation's 2027 outlook centres on $40.14, within a $32.70 to $51.65 range. That is up +13% on the projected 2026 average. That marks a +13% change versus current levels. Price action looks broadly range-bound.
By 2028, CNMD could reach as high as $55.86, with a base case around $42.27 and support toward $33.79 — roughly +19% from $35.48. A consolidation phase looks the most probable path here.
Expect CNMD to range from $34.16 to $58.61 through 2029. The $43.41 average target implies a +22% move from current prices. That is up +3% on the projected 2028 average. Momentum favours further upside here.
The CNMD price prediction for 2030 points to an average of $44.45 (low $34.49, high $61.11) — a potential gain of +25% on today's $35.48. Buyers look set to stay in control over this stretch.
In 2031, CNMD is projected to trade between $36.29 and $66.16, averaging $47.36 — a potential gain of +33% from today's $35.48. That is up +7% on the projected 2030 average. Momentum favours further upside here.
CONMED Corporation's 2032 outlook centres on $57.53, within a $43.57 to $81.54 range. That is up +21% on the projected 2031 average. That marks a +62% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, CNMD could reach as high as $89.72, with a base case around $62.46 and support toward $46.79 — roughly +76% from $35.48. Momentum favours further upside here.
Expect CNMD to range from $46.57 to $91.31 through 2034. The $62.81 average target implies a +77% move from current prices. That is up +1% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The CNMD price prediction for 2035 points to an average of $67.14 (low $49.29, high $98.74) — a potential gain of +89% on today's $35.48. Momentum favours further upside here.
In 2040, CNMD is projected to trade between $68.45 and $150.35, averaging $97.44 — a potential gain of +175% from today's $35.48. That is up +45% on the projected 2035 average. Buyers look set to stay in control over this stretch.
CONMED Corporation's 2050 outlook centres on $152.67, within a $99.62 to $252.98 range. That is up +57% on the projected 2040 average. That marks a +330% change versus current levels. Momentum favours further upside here.
Investing $1,000 in CNMD today (≈ 28.184893 CNMD) could be worth
$4,302.87
+$3,302.87 (+330%) by 2050 · US Dollar
Based on the average projected CNMD price of $152.67 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CNMDwould be worth at today's price.
$1,000 invested in CNMD on May 27, 2025 (≈ 17.307027 CNMD) would be worth
$614.05
-$385.95 (-38.6%) today · 0.61× · US Dollar
Based on a CNMD entry price of $57.78 vs. today's $35.48.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $37.01 | $958.66 | -4.1% |
| 1 month ago | $37.87 | $936.89 | -6.3% |
| 3 months ago | $45.87 | $773.49 | -22.7% |
| 6 months ago | $43.42 | $817.13 | -18.3% |
| 1 year ago | $57.78 | $614.05 | -38.6% |
| All time (5.0y) ago | $138.45 | $256.27 | -74.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CNMD forecast.
Our base-case forecast reaches $71.00 around 2040.
Implied market cap at $71.00: $2.14B
The multi-year forecast shows a bullish trajectory with steady upside through the horizon. The year-by-year path includes a 2027 average of $42.64 (ROI 14.5) and a 2028 average of $45.67 (ROI 22.7), followed by 2029 at $46.87 (ROI 25.9) and 2030 at $48.69 (ROI 30.8). By 2031 the average is $53.19 (ROI 42.9) and 2032 $64.48 (ROI 73.2), continuing to 2033 at $70.09 (ROI 88.3) and 2034 at $71.00 (ROI 90.7), then 2035 at $75.83 (ROI 103.7).
The forecast accelerates into 2040 with an average of $113.06 (ROI 203.7) and again by 2050 to $179.58 (ROI 382.4). Maximums rise accordingly to $66.97 (2030), $174.47 (2040), and $297.62 (2050). These are estimates, not guarantees, and actual results may differ.
Tap a question to reveal the answer.
The 2030 forecast shows min $37.78, avg $48.69, max $66.97, with ROI 30.8% and sentiment BULLISH.
The forecast indicates a bullish path with rising averages and positive ROI across years, including 2027 avg $42.64 (ROI 14.5), 2040 avg $113.06 (ROI 203.7), and 2050 avg $179.58 (ROI 382.4). These are estimates, not guarantees.
Yes. The forecast shows a max of $100.68 in 2033 and $103.24 in 2034, with 2033 avg $70.09.
The current price is $37.23.
The 2040 forecast shows min $79.41, avg $113.06, max $174.47, ROI 203.7, with sentiment BULLISH.
CONMED Corporation Community Discussion
0Share your CONMED Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.